DA32 Life Science Tech Acquisition Corp.

DA32 Life Science Tech Acquisition Corp., trading under the ticker DALS, is a blank-check company formed to pursue an acquisition in the life science and healthcare technology sector. The vehicle filed an 8-K with the Securities and Exchange Commission on July 30, 2021, under accession number 0001193125-21-231358, reflecting a corporate event during its post-IPO operating period. The SPAC completed its initial public offering in 2021, with the DA32 sponsor team guiding the search for a target company at the intersection of life sciences and technology. Visit SpacDesk and sign up for full data, filings history, and deal analytics on DALS and hundreds of other SPACs.